All patients (n = 650) | ||
---|---|---|
Sociodemographic characteristics (at baseline) | ||
Gender, no. Male | 505 | 77.7% |
Age, mean yr (SD) | 72.9 | 9.8 |
Age | ||
< 60 | 65 | 10.0% |
60- < 70 | 151 | 23.2% |
70- < 80 | 265 | 40.8% |
> =80 | 169 | 26.0% |
Comorbidity (CCI) | ||
0 | 280 | 43.1% |
1 | 186 | 28.6% |
≥ 2 | 149 | 22.9% |
Unknown | 35 | 5.4% |
BMI | ||
< 23 | 139 | 21.4% |
23- < 31 | 445 | 68.5% |
≥ 31 | 66 | 10.2% |
SES | ||
Low | 152 | 23.4% |
Medium | 261 | 40.2% |
High | 205 | 31.5% |
Unknown | 32 | 4.9% |
Living situation | ||
With partner | 496 | 76.3% |
Without partner | 145 | 22.3% |
Else | 9 | 1.4% |
Education | ||
Primary school | 92 | 14.2% |
High school | 151 | 23.2% |
Secondary vocational education | 262 | 40.3% |
Higher professional education | 142 | 21.8% |
Unknown | 3 | 0.5% |
Employment status | ||
Paid Job | 97 | 14.9% |
No paid job | 552 | 84.9% |
Unknown | 1 | 0.2% |
Smoking status (at baseline) | ||
Never | 109 | 16.8% |
Former | 421 | 64.8% |
Current | 144 | 22.2% |
Unknown | 6 | 0.9% |
Alcohol use | ||
Current | 471 | 72.5% |
Previous | 64 | 9.8% |
Never | 109 | 16.8% |
Unknown | 6 | 0.9% |
Clinical characteristics | ||
Histology | ||
Urothelial carcinoma | 606 | 93.2% |
Other | 44 | 6.8% |
Clinical tumour stage | ||
cT2, cN0 | 430 | 66.2% |
cT3, cN0 | 119 | 18.3% |
cT4a, cN0 | 22 | 3.4% |
any T, cN1–2 | 79 | 12.2% |
Treatment | ||
No treatment | 91 | 14.0% |
Cystectomy with neoadjuvant chemotherapy | 107 | 16.5% |
Cystectomy alone | 214 | 32.9% |
Bladder sparing treatment (chemoradiation, brachytherapy) | 104 | 16.0% |
External beam radiotherapy | 112 | 17.2% |
Systemic treatment | 22 | 3.4% |
Urinary diversiona | ||
Neobladder | 21 | 6.5% |
Bricker | 296 | 92.2% |
Ureterocutaneous anastomy | 2 | 0.6% |
Unknown | 2 | 0.6% |